Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CART19 cells |
Trade Name | |
Synonyms | CART-19 cells |
Drug Descriptions |
CART19 cells are allogeneic T lymphocytes engineered to express a CD19-targeted chimeric antigen receptor (CAR) containing a CD3 zeta chain and the TNFRSF9 (4-1BB) signaling domain, which may induce antitumor activity (PMID: 21716851). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C153118 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CART19 cells | CART19 cells | 0 | 2 |